Ingevity
Stock Forecast, Prediction & Price Target
Ingevity Financial Estimates
Ingevity Revenue Estimates
Ingevity EBITDA Estimates
Ingevity Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $1.39B N/A | $1.66B 19.89% | $1.69B 1.42% | Avg: $1.54B Low: $1.51B High: $1.57B avg. -8.70% | Avg: $1.59B Low: $1.55B High: $1.62B avg. 3.44% | ||
Net Income
% change YoY
| $118.1M N/A | $211.6M 79.17% | $-5.4M -102.55% | Avg: $162.22M Low: $113.86M High: $182.48M avg. 3104.16% | Avg: $217M Low: $205.87M High: $218.89M avg. 33.76% | ||
EBITDA
% change YoY
| $337.2M N/A | $451.5M 33.89% | $224.6M -50.25% | Avg: $430.34M Low: $421.91M High: $438.78M avg. 91.60% | Avg: $445.18M Low: $432.39M High: $453.24M avg. 3.44% | ||
EPS
% change YoY
| $2.97 N/A | $5.54 86.53% | -$0.15 -102.70% | Avg: $4.34 Low: $3.12 High: $5 avg. 2993.33% | Avg: $5.86 Low: $5.64 High: $6 avg. 35.02% | ||
Operating Expenses
% change YoY
| $205.6M N/A | $229.1M 11.42% | $183.7M -19.81% | Avg: $179.43M Low: $175.91M High: $182.95M avg. -2.32% | Avg: $185.61M Low: $180.28M High: $188.97M avg. 3.44% | ||
FAQ
What is Ingevity stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 1568.96% in 2025-2026.
We have gathered data from 4 analysts. Their low estimate is 113.86M, average is 162.22M and high is 182.48M.
What is Ingevity stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -2.63% in 2025-2026.
We have gathered data from 4 analysts. Their low revenue estimate is $1.51B, average is $1.54B and high is $1.57B.
What is Ingevity stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 1514.17% in 2025-2026.
We have gathered data from 4 analysts. Their low earnings per share estimate is $3.12, average is $4.34 and high is $5.
What is the best performing analyst?
In the last twelve months analysts have been covering Ingevity stock. The most successful analyst is John McNulty.